TY - JOUR AU - Gandjour, Afschin PY - 2020 DA - 2020/03/23 TI - A proportional rule for setting reimbursement prices of new drugs and its mathematical consistency JO - BMC Health Services Research SP - 240 VL - 20 IS - 1 AB - Value-based pricing (VBP) of new drugs has been suggested both as a way to control health expenditures and to maximize health benefits based on the available resources. The purpose of this work is to present a simple mathematical proof showing that prices of new drugs are set in a mathematically consistent way when the sum of intervention and downstream costs is proportional to the size of health benefits. Such proportional relationship underlies the efficiency-frontier method used by the German Institute for Quality and Efficiency in Health Care (IQWiG). SN - 1472-6963 UR - https://doi.org/10.1186/s12913-020-5055-4 DO - 10.1186/s12913-020-5055-4 ID - Gandjour2020 ER -